Literature DB >> 31022463

HDAC2, but not HDAC1, regulates Kv1.2 expression to mediate neuropathic pain in CCI rats.

Zhihua Li1, Yanyan Guo1, Xiuhua Ren1, Lina Rong1, Minjie Huang1, Jing Cao2, Weidong Zang3.   

Abstract

The expression of potassium ion channel subunit 1.2 (Kv1.2) in the dorsal root ganglion (DRG) influences the excitability of neurons, which contributes to the induction and development of neuropathic pain (NPP); however, the molecular mechanisms underlying the downregulation of Kv1.2 in NPP remain unknown. Histone deacetylase (HDAC) inhibitors are reported to attenuate the development of pain hypersensitivity in rats with NPP. Whether HDAC inhibitors contribute to regulation of Kv1.2 expression, and which specific HDAC subunit is involved in NPP, remain unexplored. In this study we established a chronic constrictive injury (CCI) model and used western blot, quantitative real-time PCR, immunostaining, intrathecal injection, and siRNA methods to explore which HDAC subunit is involved in regulating Kv1.2 expression to mediate NPP. Our results demonstrated that nerve injury led to upregulation of HDAC1 expression in the DRG, and of HDAC2 in the DRG and spinal cord. Double-labeling immunofluorescence histochemistry showed that Kv1.2 principally co-localized with HDAC2, but not HDAC1, in NF200-positive large neurons of the DRG. Intrathecal injection with the HDAC inhibitor, suberoylanilide hydroxamic acid, attenuated mechanical and thermal hypersensitivity and reversed the decreased expression of Kv1.2 in rats with CCI. Furthermore, treatment with HDAC2, but not HDAC1, siRNA also relieved mechanical and thermal hypersensitivity and upregulated the Kv1.2 expression in this model. In vitro transfection of PC12 cells with HDAC2 and HDAC1 siRNA confirmed that only HDAC2 siRNA could regulate the expression of Kv1.2. These findings suggest that HDAC2, but not HDAC1, is involved in NPP through regulation of Kv1.2 expression.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Kv1.2; histone deacetylase; neuropathic pain; small interfering RNA; suberoylanilide hydroxamic acid

Year:  2019        PMID: 31022463     DOI: 10.1016/j.neuroscience.2019.03.033

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

Review 1.  Regulation of Central Nervous System Development by Class I Histone Deacetylases.

Authors:  Santosh R D'Mello
Journal:  Dev Neurosci       Date:  2020-01-24       Impact factor: 2.984

2.  Differential effects of HDAC inhibitors on PPN oscillatory activity in vivo.

Authors:  Veronica Bisagno; Maria Alejandra Bernardi; Sara Sanz Blasco; Francisco J Urbano; Edgar Garcia-Rill
Journal:  Neuropharmacology       Date:  2019-12-23       Impact factor: 5.250

3.  Characterization of Acetylation of Histone H3 at Lysine 9 in the Trigeminal Ganglion of a Rat Trigeminal Neuralgia Model.

Authors:  Wenbin Wei; Yuemin Liu; Yating Qiu; Minjie Chen; Yiwen Wang; Zixiang Han; Ying Chai
Journal:  Oxid Med Cell Longev       Date:  2022-05-04       Impact factor: 7.310

4.  Epigenetic regulation of cardiac electrophysiology in atrial fibrillation: HDAC2 determines action potential duration and suppresses NRSF in cardiomyocytes.

Authors:  Patrick Lugenbiel; Katharina Govorov; Pascal Syren; Ann-Kathrin Rahm; Teresa Wieder; Maximilian Wunsch; Nadine Weiberg; Emili Manolova; Dominik Gramlich; Rasmus Rivinius; Daniel Finke; Lorenz H Lehmann; Patrick A Schweizer; Derk Frank; Fadwa A El Tahry; Claus Bruehl; Tanja Heimberger; Steffi Sandke; Tanja Weis; Patrick Most; Bastian Schmack; Arjang Ruhparwar; Matthias Karck; Norbert Frey; Hugo A Katus; Dierk Thomas
Journal:  Basic Res Cardiol       Date:  2021-02-25       Impact factor: 17.165

5.  NF-κB p65-dependent transcriptional regulation of histone deacetylase 2 contributes to the chronic constriction injury-induced neuropathic pain via the microRNA-183/TXNIP/NLRP3 axis.

Authors:  Jiamin Miao; Xuelong Zhou; Tianjiao Ji; Gang Chen
Journal:  J Neuroinflammation       Date:  2020-07-28       Impact factor: 8.322

Review 6.  Peripheral Voltage-Gated Cation Channels in Neuropathic Pain and Their Potential as Therapeutic Targets.

Authors:  Sascha R A Alles; Peter A Smith
Journal:  Front Pain Res (Lausanne)       Date:  2021-12-13

7.  The role of botulinum toxin type A related axon transport in neuropathic pain induced by chronic constriction injury.

Authors:  Huilian Bu; Pengfei Jiao; Xiaochong Fan; Yan Gao; Lirong Zhang; Haiming Guo
Journal:  Korean J Pain       Date:  2022-10-01

8.  Cdyl Deficiency Brakes Neuronal Excitability and Nociception through Promoting Kcnb1 Transcription in Peripheral Sensory Neurons.

Authors:  Zhao-Wei Sun; Jarod M Waybright; Serap Beldar; Lu Chen; Caroline A Foley; Jacqueline L Norris-Drouin; Tian-Jie Lyu; Aiping Dong; Jinrong Min; Yu-Pu Wang; Lindsey I James; Yun Wang
Journal:  Adv Sci (Weinh)       Date:  2022-02-04       Impact factor: 16.806

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.